Mobilise App Lab SME
smeAlloted
GMP
₹11
smeAlloted
Mobilise App Lab SME
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹11
(+13.75%) Est. Gain
Investment Timeline
✓
IPO Open
23 Feb 2026
✓
IPO Close
25 Feb 2026
✓
Allotment
26 Feb 2026
🔔
Listing
2 Mar 2026
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
NEUTRAL
54.1/100
🎯 Application Strategy
Action: ⚠️ NEUTRAL - Mixed signals, proceed with caution
Lots: Single lot only for diversification
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
🚀 Exceptional subscription! Massive oversubscription across all categories
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
⚠️ Limited listing gains expected (0-5%)
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹75.0 - ₹80.0
📦Lot Size
1600 shares
💰Issue Size
₹20.10 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Mobilise App Lab SME?
As of today, the Grey Market Premium (GMP) for Mobilise App Lab SME is ₹11, which is approximately (+13.75%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Mobilise App Lab SME?
Our AI algorithm currently rates this IPO as "NEUTRAL" with a score of 54.1/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Mobilise App Lab SME be announced?
The allotment status for Mobilise App Lab SME is expected to be finalized on 26 Feb 2026. Investors can check their status on the registrar's website.
What is the listing date for Mobilise App Lab SME?
Shares of Mobilise App Lab SME are proposed to be listed on stock exchanges on 2 Mar 2026.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.